FOLD
Amicus Therapeutics Inc.
Company Overview
| Mkt Cap | $2.57B | Price | $9.03 |
| Volume | 4.89M | Change | +1.46% |
| P/E Ratio | -45.8 | Open | $8.90 |
| Revenue | $528.3M | Prev Close | $8.90 |
| Net Income | $-56.1M | 52W Range | $5.51 - $12.65 |
| Div Yield | N/A | Target | $15.36 |
| Overall | 58 | Value | 20 |
| Quality | 65 | Technical | 91 |
No chart data available
Stock Overview
Updated DailyAmicus Therapeutics Inc. (FOLD) is a leading Healthcare company in the Biotechnology industry, currently trading at $9.03 with a market capitalization of $2.57 billion. The stock is trading in the middle of its 52-week range, demonstrating solid quality metrics with a MarketXLS quality score of 65.
Today's trading session shows FOLD with a volume of 4.89 million shares. The stock opened down 0.00% from yesterday's close of $8.90. Current analyst estimates project earnings of $0.03 per share for this year, with next year targeting $0.41.
FOLD demonstrates very strong technical momentum based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including BIIB, GSK, ESPR, BMRN, NVO.
Key investment considerations for FOLD include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 70.1%. The stock shows expensive valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 07:33 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FOLD | $9.03 | +1.5% | 4.89M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Amicus Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW